MedTrace Logo

Screening of Lysosomal Storage Disorders Diseases in Minority Groups

NCT03812042 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2019-01-22

No results posted yet for this study

Summary

Aim is to undertake a screening study that identifies undiagnosed patients with LSDs and determine the prevalence of these diseases with special focus on underrepresented minority groups.

Conditions

  • Lysosomal Storage Diseases

Interventions

DIAGNOSTIC_TEST

Enzyme assay and molecular sequencing

Enzyme assay and molecular sequencing on relevant samples conducted from left over blood samples

Sponsors & Collaborators

  • Lysosomal and Rare Disorders Research and Treatment Center, Inc.

    lead OTHER

Principal Investigators

  • Renuka Limgala, PhD · LDRTC

  • Margarita M Ivanova, PhD · LDRTC

  • Ozlem Goker-Alpan, MD · LDRTC

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-17
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03812042 on ClinicalTrials.gov